Global Opioid Induced Constipation (OIC) Drug Market Insights and Forecast to 2026

Global Opioid Induced Constipation (OIC) Drug Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Opioid Induced Constipation (OIC) Drug Product Introduction
1.2 Market Segments
1.3 Key Opioid Induced Constipation (OIC) Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Type
1.4.2 Lubiprostone
1.4.3 Methyl Naltrexone Bromide
1.4.4 Naldemedine
1.4.5 Alvimopan
1.4.6 Other
1.5 Market by Application
1.5.1 Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Opioid Induced Constipation (OIC) Drug Market Size, Estimates and Forecasts
2.1.1 Global Opioid Induced Constipation (OIC) Drug Revenue 2015-2026
2.1.2 Global Opioid Induced Constipation (OIC) Drug Sales 2015-2026
2.2 Global Opioid Induced Constipation (OIC) Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Opioid Induced Constipation (OIC) Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Opioid Induced Constipation (OIC) Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Opioid Induced Constipation (OIC) Drug Competitor Landscape by Players
3.1 Opioid Induced Constipation (OIC) Drug Sales by Manufacturers
3.1.1 Opioid Induced Constipation (OIC) Drug Sales by Manufacturers (2015-2020)
3.1.2 Opioid Induced Constipation (OIC) Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers
3.2.1 Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers (2015-2020)
3.2.2 Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Opioid Induced Constipation (OIC) Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Opioid Induced Constipation (OIC) Drug Revenue in 2019
3.2.5 Global Opioid Induced Constipation (OIC) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Opioid Induced Constipation (OIC) Drug Price by Manufacturers
3.4 Opioid Induced Constipation (OIC) Drug Manufacturing Base Distribution, Product Types
3.4.1 Opioid Induced Constipation (OIC) Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Opioid Induced Constipation (OIC) Drug Product Type
3.4.3 Date of International Manufacturers Enter into Opioid Induced Constipation (OIC) Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Opioid Induced Constipation (OIC) Drug Market Size by Type (2015-2020)
4.1.1 Global Opioid Induced Constipation (OIC) Drug Sales by Type (2015-2020)
4.1.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2015-2020)
4.1.3 Opioid Induced Constipation (OIC) Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Opioid Induced Constipation (OIC) Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Type (2021-2026)
4.2.3 Opioid Induced Constipation (OIC) Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Opioid Induced Constipation (OIC) Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Opioid Induced Constipation (OIC) Drug Market Size by Application (2015-2020)
5.1.1 Global Opioid Induced Constipation (OIC) Drug Sales by Application (2015-2020)
5.1.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Application (2015-2020)
5.1.3 Opioid Induced Constipation (OIC) Drug Price by Application (2015-2020)
5.2 Opioid Induced Constipation (OIC) Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Opioid Induced Constipation (OIC) Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Opioid Induced Constipation (OIC) Drug by Country
6.1.1 North America Opioid Induced Constipation (OIC) Drug Sales by Country
6.1.2 North America Opioid Induced Constipation (OIC) Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Type
6.3 North America Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Opioid Induced Constipation (OIC) Drug by Country
7.1.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Country
7.1.2 Europe Opioid Induced Constipation (OIC) Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Type
7.3 Europe Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Opioid Induced Constipation (OIC) Drug by Region
8.1.1 Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Region
8.1.2 Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Type
8.3 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Opioid Induced Constipation (OIC) Drug by Country
9.1.1 Latin America Opioid Induced Constipation (OIC) Drug Sales by Country
9.1.2 Latin America Opioid Induced Constipation (OIC) Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Type
9.3 Central & South America Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug by Country
10.1.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Country
10.1.2 Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Type
10.3 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Ironwood Pharmaceuticals
11.1.1 Ironwood Pharmaceuticals Corporation Information
11.1.2 Ironwood Pharmaceuticals Description and Business Overview
11.1.3 Ironwood Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Products Offered
11.1.5 Ironwood Pharmaceuticals Related Developments
11.2 Daiichi Sankyo Co
11.2.1 Daiichi Sankyo Co Corporation Information
11.2.2 Daiichi Sankyo Co Description and Business Overview
11.2.3 Daiichi Sankyo Co Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Products Offered
11.2.5 Daiichi Sankyo Co Related Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description and Business Overview
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Opioid Induced Constipation (OIC) Drug Products Offered
11.3.5 Pfizer Related Developments
11.4 Progenics Pharmaceuticals
11.4.1 Progenics Pharmaceuticals Corporation Information
11.4.2 Progenics Pharmaceuticals Description and Business Overview
11.4.3 Progenics Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Products Offered
11.4.5 Progenics Pharmaceuticals Related Developments
11.5 Shionogi &
11.5.1 Shionogi & Corporation Information
11.5.2 Shionogi & Description and Business Overview
11.5.3 Shionogi & Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Shionogi & Opioid Induced Constipation (OIC) Drug Products Offered
11.5.5 Shionogi & Related Developments
11.6 Allergan
11.6.1 Allergan Corporation Information
11.6.2 Allergan Description and Business Overview
11.6.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Allergan Opioid Induced Constipation (OIC) Drug Products Offered
11.6.5 Allergan Related Developments
11.7 Nektar Therapeutics
11.7.1 Nektar Therapeutics Corporation Information
11.7.2 Nektar Therapeutics Description and Business Overview
11.7.3 Nektar Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Products Offered
11.7.5 Nektar Therapeutics Related Developments
11.8 Purdue Pharma
11.8.1 Purdue Pharma Corporation Information
11.8.2 Purdue Pharma Description and Business Overview
11.8.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drug Products Offered
11.8.5 Purdue Pharma Related Developments
11.9 S.L.A. Pharma
11.9.1 S.L.A. Pharma Corporation Information
11.9.2 S.L.A. Pharma Description and Business Overview
11.9.3 S.L.A. Pharma Sales, Revenue and Gross Margin (2015-2020)
11.9.4 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Products Offered
11.9.5 S.L.A. Pharma Related Developments
11.10 Mundipharma International Limited
11.10.1 Mundipharma International Limited Corporation Information
11.10.2 Mundipharma International Limited Description and Business Overview
11.10.3 Mundipharma International Limited Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Products Offered
11.10.5 Mundipharma International Limited Related Developments
11.1 Ironwood Pharmaceuticals
11.1.1 Ironwood Pharmaceuticals Corporation Information
11.1.2 Ironwood Pharmaceuticals Description and Business Overview
11.1.3 Ironwood Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Products Offered
11.1.5 Ironwood Pharmaceuticals Related Developments
11.12 Takeda Pharmaceutical Company Limited
11.12.1 Takeda Pharmaceutical Company Limited Corporation Information
11.12.2 Takeda Pharmaceutical Company Limited Description and Business Overview
11.12.3 Takeda Pharmaceutical Company Limited Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Takeda Pharmaceutical Company Limited Products Offered
11.12.5 Takeda Pharmaceutical Company Limited Related Developments
11.13 Theravance Biopharma
11.13.1 Theravance Biopharma Corporation Information
11.13.2 Theravance Biopharma Description and Business Overview
11.13.3 Theravance Biopharma Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Theravance Biopharma Products Offered
11.13.5 Theravance Biopharma Related Developments
11.14 Bausch Health
11.14.1 Bausch Health Corporation Information
11.14.2 Bausch Health Description and Business Overview
11.14.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Bausch Health Products Offered
11.14.5 Bausch Health Related Developments
11.15 Cosmo Pharmaceuticals SA
11.15.1 Cosmo Pharmaceuticals SA Corporation Information
11.15.2 Cosmo Pharmaceuticals SA Description and Business Overview
11.15.3 Cosmo Pharmaceuticals SA Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Cosmo Pharmaceuticals SA Products Offered
11.15.5 Cosmo Pharmaceuticals SA Related Developments
11.16 Daewoong Pharmaceutical
11.16.1 Daewoong Pharmaceutical Corporation Information
11.16.2 Daewoong Pharmaceutical Description and Business Overview
11.16.3 Daewoong Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Daewoong Pharmaceutical Products Offered
11.16.5 Daewoong Pharmaceutical Related Developments
11.17 C.B. Fleet Company
11.17.1 C.B. Fleet Company Corporation Information
11.17.2 C.B. Fleet Company Description and Business Overview
11.17.3 C.B. Fleet Company Sales, Revenue and Gross Margin (2015-2020)
11.17.4 C.B. Fleet Company Products Offered
11.17.5 C.B. Fleet Company Related Developments
11.18 Sucampo Pharmaceuticals
11.18.1 Sucampo Pharmaceuticals Corporation Information
11.18.2 Sucampo Pharmaceuticals Description and Business Overview
11.18.3 Sucampo Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Sucampo Pharmaceuticals Products Offered
11.18.5 Sucampo Pharmaceuticals Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Opioid Induced Constipation (OIC) Drug Market Estimates and Projections by Region
12.1.1 Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Regions 2021-2026
12.2 North America Opioid Induced Constipation (OIC) Drug Market Size Forecast (2021-2026)
12.2.1 North America: Opioid Induced Constipation (OIC) Drug Sales Forecast (2021-2026)
12.2.2 North America: Opioid Induced Constipation (OIC) Drug Revenue Forecast (2021-2026)
12.2.3 North America: Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Opioid Induced Constipation (OIC) Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Opioid Induced Constipation (OIC) Drug Sales Forecast (2021-2026)
12.3.2 Europe: Opioid Induced Constipation (OIC) Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Opioid Induced Constipation (OIC) Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Opioid Induced Constipation (OIC) Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Opioid Induced Constipation (OIC) Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Opioid Induced Constipation (OIC) Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Opioid Induced Constipation (OIC) Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Opioid Induced Constipation (OIC) Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Opioid Induced Constipation (OIC) Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Opioid Induced Constipation (OIC) Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Opioid Induced Constipation (OIC) Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Opioid Induced Constipation (OIC) Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Opioid Induced Constipation (OIC) Drug Market Segments
Table 2. Ranking of Global Top Opioid Induced Constipation (OIC) Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Lubiprostone
Table 5. Major Manufacturers of Methyl Naltrexone Bromide
Table 6. Major Manufacturers of Naldemedine
Table 7. Major Manufacturers of Alvimopan
Table 8. Major Manufacturers of Other
Table 9. Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Application 2020-2026 (K Units)
Table 10. Global Opioid Induced Constipation (OIC) Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 11. Global Opioid Induced Constipation (OIC) Drug Sales by Regions 2015-2020 (K Units)
Table 12. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Opioid Induced Constipation (OIC) Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Opioid Induced Constipation (OIC) Drug Sales by Manufacturers (2015-2020) (K Units)
Table 15. Global Opioid Induced Constipation (OIC) Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Opioid Induced Constipation (OIC) Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Opioid Induced Constipation (OIC) Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Induced Constipation (OIC) Drug as of 2019)
Table 18. Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Opioid Induced Constipation (OIC) Drug Price (2015-2020) (USD/Unit)
Table 21. Opioid Induced Constipation (OIC) Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Opioid Induced Constipation (OIC) Drug Product Type
Table 23. Date of International Manufacturers Enter into Opioid Induced Constipation (OIC) Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Opioid Induced Constipation (OIC) Drug Sales by Type (2015-2020) (K Units)
Table 26. Global Opioid Induced Constipation (OIC) Drug Sales Share by Type (2015-2020)
Table 27. Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Opioid Induced Constipation (OIC) Drug Revenue Share by Type (2015-2020)
Table 29. Opioid Induced Constipation (OIC) Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 30. Global Opioid Induced Constipation (OIC) Drug Sales by Application (2015-2020) (K Units)
Table 31. Global Opioid Induced Constipation (OIC) Drug Sales Share by Application (2015-2020)
Table 32. North America Opioid Induced Constipation (OIC) Drug Sales by Country (2015-2020) (K Units)
Table 33. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2015-2020)
Table 34. North America Opioid Induced Constipation (OIC) Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Opioid Induced Constipation (OIC) Drug Sales by Type (2015-2020) (K Units)
Table 37. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2015-2020)
Table 38. North America Opioid Induced Constipation (OIC) Drug Sales by Application (2015-2020) (K Units)
Table 39. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2015-2020) (K Units)
Table 41. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2015-2020) (K Units)
Table 45. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Opioid Induced Constipation (OIC) Drug Sales by Application (2015-2020) (K Units)
Table 47. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Region (2015-2020) (K Units)
Table 49. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Type (2015-2020) (K Units)
Table 53. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Application (2015-2020) (K Units)
Table 55. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Opioid Induced Constipation (OIC) Drug Sales by Country (2015-2020) (K Units)
Table 57. Latin America Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Opioid Induced Constipation (OIC) Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Opioid Induced Constipation (OIC) Drug Sales by Type (2015-2020) (K Units)
Table 61. Latin America Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Opioid Induced Constipation (OIC) Drug Sales by Application (2015-2020) (K Units)
Table 63. Latin America Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2015-2020) (K Units)
Table 65. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2015-2020) (K Units)
Table 69. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Application (2015-2020) (K Units)
Table 71. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2015-2020)
Table 72. Ironwood Pharmaceuticals Corporation Information
Table 73. Ironwood Pharmaceuticals Description and Major Businesses
Table 74. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 75. Ironwood Pharmaceuticals Product
Table 76. Ironwood Pharmaceuticals Recent Development
Table 77. Daiichi Sankyo Co Corporation Information
Table 78. Daiichi Sankyo Co Description and Major Businesses
Table 79. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. Daiichi Sankyo Co Product
Table 81. Daiichi Sankyo Co Recent Development
Table 82. Pfizer Corporation Information
Table 83. Pfizer Description and Major Businesses
Table 84. Pfizer Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. Pfizer Product
Table 86. Pfizer Recent Development
Table 87. Progenics Pharmaceuticals Corporation Information
Table 88. Progenics Pharmaceuticals Description and Major Businesses
Table 89. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. Progenics Pharmaceuticals Product
Table 91. Progenics Pharmaceuticals Recent Development
Table 92. Shionogi & Corporation Information
Table 93. Shionogi & Description and Major Businesses
Table 94. Shionogi & Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. Shionogi & Product
Table 96. Shionogi & Recent Development
Table 97. Allergan Corporation Information
Table 98. Allergan Description and Major Businesses
Table 99. Allergan Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. Allergan Product
Table 101. Allergan Recent Development
Table 102. Nektar Therapeutics Corporation Information
Table 103. Nektar Therapeutics Description and Major Businesses
Table 104. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. Nektar Therapeutics Product
Table 106. Nektar Therapeutics Recent Development
Table 107. Purdue Pharma Corporation Information
Table 108. Purdue Pharma Description and Major Businesses
Table 109. Purdue Pharma Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. Purdue Pharma Product
Table 111. Purdue Pharma Recent Development
Table 112. S.L.A. Pharma Corporation Information
Table 113. S.L.A. Pharma Description and Major Businesses
Table 114. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 115. S.L.A. Pharma Product
Table 116. S.L.A. Pharma Recent Development
Table 117. Mundipharma International Limited Corporation Information
Table 118. Mundipharma International Limited Description and Major Businesses
Table 119. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 120. Mundipharma International Limited Product
Table 121. Mundipharma International Limited Recent Development
Table 122. Ono Pharmaceutical Corporation Information
Table 123. Ono Pharmaceutical Description and Major Businesses
Table 124. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 125. Ono Pharmaceutical Product
Table 126. Ono Pharmaceutical Recent Development
Table 127. Takeda Pharmaceutical Company Limited Corporation Information
Table 128. Takeda Pharmaceutical Company Limited Description and Major Businesses
Table 129. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 130. Takeda Pharmaceutical Company Limited Product
Table 131. Takeda Pharmaceutical Company Limited Recent Development
Table 132. Theravance Biopharma Corporation Information
Table 133. Theravance Biopharma Description and Major Businesses
Table 134. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 135. Theravance Biopharma Product
Table 136. Theravance Biopharma Recent Development
Table 137. Bausch Health Corporation Information
Table 138. Bausch Health Description and Major Businesses
Table 139. Bausch Health Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 140. Bausch Health Product
Table 141. Bausch Health Recent Development
Table 142. Cosmo Pharmaceuticals SA Corporation Information
Table 143. Cosmo Pharmaceuticals SA Description and Major Businesses
Table 144. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 145. Cosmo Pharmaceuticals SA Product
Table 146. Cosmo Pharmaceuticals SA Recent Development
Table 147. Daewoong Pharmaceutical Corporation Information
Table 148. Daewoong Pharmaceutical Description and Major Businesses
Table 149. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 150. Daewoong Pharmaceutical Product
Table 151. Daewoong Pharmaceutical Recent Development
Table 152. C.B. Fleet Company Corporation Information
Table 153. C.B. Fleet Company Description and Major Businesses
Table 154. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 155. C.B. Fleet Company Product
Table 156. C.B. Fleet Company Recent Development
Table 157. Sucampo Pharmaceuticals Corporation Information
Table 158. Sucampo Pharmaceuticals Description and Major Businesses
Table 159. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 160. Sucampo Pharmaceuticals Product
Table 161. Sucampo Pharmaceuticals Recent Development
Table 162. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Regions (2021-2026) (K Units)
Table 163. Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by Regions (2021-2026)
Table 164. Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 165. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 166. North America: Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2021-2026) (K Units)
Table 167. North America: Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 168. Europe: Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2021-2026) (K Units)
Table 169. Europe: Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 170. Asia Pacific: Opioid Induced Constipation (OIC) Drug Sales Forecast by Region (2021-2026) (K Units)
Table 171. Asia Pacific: Opioid Induced Constipation (OIC) Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 172. Latin America: Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2021-2026) (K Units)
Table 173. Latin America: Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 174. Middle East and Africa: Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2021-2026) (K Units)
Table 175. Middle East and Africa: Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 176. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 177. Key Challenges
Table 178. Market Risks
Table 179. Main Points Interviewed from Key Opioid Induced Constipation (OIC) Drug Players
Table 180. Opioid Induced Constipation (OIC) Drug Customers List
Table 181. Opioid Induced Constipation (OIC) Drug Distributors List
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioid Induced Constipation (OIC) Drug Product Picture
Figure 2. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Lubiprostone Product Picture
Figure 4. Methyl Naltrexone Bromide Product Picture
Figure 5. Naldemedine Product Picture

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs